Supplementary Figure II.
Example Ca 2+ add-back signals in human saphenous vein VSMCs with and without store-depletion and showing comparison of effects of two chemically-different store-depletion agents, thapsigargin (TG) and cyclopiazonic acid (CPA). Intracellular Ca 2+ was measured in cells pre-treated (as indicated below) in Ca 2+ -free bath solution for 30 min and then exposed to 0.2 mM extracellular Ca 2+ as indicated by the horizontal bar labeled 'add-back', except for one group of cells where the Ca 2+ was not added back (0 Ca 2+ ). The pre-treatments in addition to the Ca 2+ -free solution were: 1 μM TG; 10 μM CPA; 1 μM TG plus 10 μM CPA (TG+CPA); 0.2 % dimethylsulphoxide (DMSO) as the vehicle control for TG and CPA; or no TG, CPA or DMSO (none).
Supplementary Figure III.
Validation and specificity of siRNA knock-down of Orai expression. See Supplementary Table I for Figure 1a . For N=16 per individual experiment, intracellular Ca 2+ measurements from VSMCs pre-treated with 1 μM thapsigargin in Ca 2+ -free bath solution for 30 min and then exposed to 0.2 mM extracellular Ca 2+ as indicated by the horizontal bars: comparing control (scrambled) siRNA with Orai1 siRNA 1 (a), Orai2 siRNA (b), Orai3 siRNA (c), Orai2 and Orai3 siRNAs (d) and Orai1 siRNA 2 (e); and comparing DNA vector with Orai1 R91W mutant (dominant negative) (f).
Supplementary Figure VI.
In support of the dotted curve in Fig 2b, the graph shows the mean rate of rise data points without normalization and with the fitted Hill equation. The y-axis is the linear slope of the initial rate of rise of the fura-2 fluorescence after extracellular Ca 2+ was added to the medium. 
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